|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...4748495051525354555657...110111» |
- | Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Trial completion, Gene therapy, Metastases: Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer (clinicaltrials.gov) - Apr 27, 2015
P1, N=0, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed
- | Trial completion, Metastases: Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer (clinicaltrials.gov) - Apr 27, 2015
P1, N=0, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- ||| Enrollment open: Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers (clinicaltrials.gov) - Apr 26, 2015
P=N/A, N=64, Recruiting, Sponsor: University of Washington
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- medroxyprogesterone injection / Generic mfg.
Trial primary completion date, Adverse events: Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects (clinicaltrials.gov) - Apr 23, 2015
P3, N=45, Active, not recruiting, Sponsor: Nationwide Children's Hospital
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2014 --> Apr 2015
- Taltorvic (ridaforolimus) / Takeda, Merck (MSD)
Trial primary completion date: Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids (clinicaltrials.gov) - Apr 23, 2015
P1, N=24, Active, not recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Trial primary completion date: Oct 2014 --> Apr 2015 Trial primary completion date: May 2015 --> Dec 2015
- Enrollment closed, Enrollment change, Trial primary completion date, Metastases: A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer (clinicaltrials.gov) - Apr 23, 2015
P1, N=35, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Trial primary completion date: May 2015 --> Dec 2015 Recruiting --> Active, not recruiting | N=24 --> 35 | Trial primary completion date: Mar 2015 --> Jan 2016
- Trial completion: Decisionmaking for Abnormal Uterine Bleeding (AUB) (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=380, Completed, Sponsor: Indiana University
Recruiting --> Active, not recruiting | N=24 --> 35 | Trial primary completion date: Mar 2015 --> Jan 2016 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: Embryo Developmental Capacity After Egg Banking in an Ovum Donation Program (clinicaltrials.gov) - Apr 22, 2015
P4, N=625, Completed, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Nov 2012 --> May 2014
- mapatumumab (HGS-ETR1) / GSK
Trial completion, Combination therapy, Metastases: Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer (clinicaltrials.gov) - Apr 22, 2015
P1/2, N=9, Completed, Sponsor: University Medical Centre Groningen
Recruiting --> Completed | Trial primary completion date: Nov 2012 --> May 2014 Active, not recruiting --> Completed
- Trial primary completion date: Outcomes of Delivery in Patients With Dyspareunia (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=200, Recruiting, Sponsor: Hadassah Medical Organization
Active, not recruiting --> Completed Trial primary completion date: Feb 2015 --> Dec 2015
- Enrollment change: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=170, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Feb 2015 --> Dec 2015 N=520 --> 170
- New trial: Novel Approach for Embryo Transfer Medium by Adding Cytokine to Hyaluronan Enriched Embryo Transfer Medium (Embryo Glue) (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=300, Recruiting, Sponsor: Ibn Sina Hospital
- Trial completion: Rad_PBS;Radical_PBS: Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=177, Completed, Sponsor: University Magna Graecia
N=520 --> 170 Recruiting --> Completed
- |||||||||| New P3 trial: NACOPRAD: NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB (clinicaltrials.gov) - Apr 21, 2015
P3, N=534, Not yet recruiting, Sponsor: Charite University, Berlin, Germany
- Prolia (denosumab) / Amgen, Daiichi Sankyo
New P2 trial: TNFSF11 Inhibition and Fertility: a Prospective Study (clinicaltrials.gov) - Apr 21, 2015
P2, N=15, Not yet recruiting, Sponsor: Martin Blomberg Jensen
- prednisone / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Male Infertility Related With Post Infection Inflammatory Syndrome (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=200, Active, not recruiting, Sponsor: Assistance Publique - H
Recruiting --> Completed Recruiting --> Active, not recruiting | N=600 --> 200 | Trial primary completion date: Sep 2014 --> May 2015
- |||| BNC105 / Bionomics
Trial completion: BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients (clinicaltrials.gov) - Apr 21, 2015
P1/2, N=134, Completed, Sponsor: Hoosier Cancer Research Network
Recruiting --> Active, not recruiting | N=600 --> 200 | Trial primary completion date: Sep 2014 --> May 2015 Recruiting --> Completed
- New trial, Preclinical: Adding Cytokines to In Vitro Human Culture Media to Improve Embryogenesis and Implantation (clinicaltrials.gov) - Apr 20, 2015
P=N/A, N=300, Recruiting, Sponsor: Ibn Sina Hospital
- || Enrollment closed, Trial primary completion date: Lymph Node Counts in Endometrial Cancer Staging (clinicaltrials.gov) - Apr 20, 2015
P=N/A, N=120, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Sep 2015
- Preclinical, Trial primary completion date: Sequential vs. Monophasic Media Impact Trial (SuMMIT) (clinicaltrials.gov) - Apr 19, 2015
P4, N=200, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Aug 2015 --> Dec 2015
- Trial primary completion date: Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=122, Completed, Sponsor: Ain Shams University
Trial primary completion date: Aug 2015 --> Dec 2015 Trial primary completion date: Jan 2015 --> Aug 2014
- Retrospective data, Trial primary completion date: Retrospective Database Studies (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=10000, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Trial primary completion date: Jan 2015 --> Aug 2014 Trial primary completion date: Dec 2014 --> Dec 2016
- Trial primary completion date: LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study (clinicaltrials.gov) - Apr 19, 2015
P0, N=60, Suspended, Sponsor: CDA Research Group, Inc.
Trial primary completion date: Dec 2014 --> Dec 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=220, Recruiting, Sponsor: Memorial Sloan Kettering Cancer Center.
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial primary completion date: Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=8, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center.
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Apr 2015 --> Apr 2016
- Trial primary completion date, Oncolytic virus: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) - Apr 19, 2015
P1, N=46, Active, not recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Effectiveness of Homeopathic Treatment in Female Infertility (clinicaltrials.gov) - Apr 19, 2015
P3, N=40, Recruiting, Sponsor: Fr Muller Homoeopathic Medical College
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2016
- Trial primary completion date: Electro-acupuncture and Assisted Reproductive Technology (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=16, Terminated, Sponsor: National University of Health Sciences
Trial primary completion date: Dec 2014 --> Dec 2016 Trial primary completion date: Nov 2012 --> Mar 2012
- Trial primary completion date: Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia (clinicaltrials.gov) - Apr 18, 2015
P=N/A, N=65, Recruiting, Sponsor: Case Comprehensive Cancer Center
Trial primary completion date: Nov 2012 --> Mar 2012 Trial primary completion date: Mar 2015 --> Sep 2015
- |||| progesterone / Generic mfg., dydrogesterone / Generic mfg.
Trial primary completion date: Lotus It: A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization (clinicaltrials.gov) - Apr 18, 2015
P3, N=1066, Recruiting, Sponsor: Abbott
Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Feb 2015 --> Sep 2015
- Votrient (pazopanib) / Novartis, BeiGene
Trial primary completion date, Combination therapy: PAZPET-1: [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (clinicaltrials.gov) - Apr 18, 2015
P1, N=17, Recruiting, Sponsor: Imperial College London
Trial primary completion date: Feb 2015 --> Sep 2015 Trial primary completion date: May 2014 --> May 2015
- New trial: Adding Insulin to IVF Culture Media Significantly Improve Outcome (clinicaltrials.gov) - Apr 17, 2015
P=N/A, N=300, Recruiting, Sponsor: Ibn Sina Hospital
- dexamethasone injection / Generic mfg.
Trial completion: Use of Dexamethasone in Uterine Artery Embolization (clinicaltrials.gov) - Apr 17, 2015
P=N/A, N=64, Completed, Sponsor: Severance Hospital
Trial primary completion date: May 2014 --> May 2015 Recruiting --> Completed
- Trial primary completion date: Androgen Metabolism and Reproductive Outcome (clinicaltrials.gov) - Apr 17, 2015
P=N/A, N=400, Recruiting, Sponsor: Medical University of Graz
Recruiting --> Completed Trial primary completion date: Oct 2014 --> Jul 2015
- New trial: VLSCBCPPTLIL: Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=60, Recruiting, Sponsor: Daniela de Fátima Teixeira da Silva
- New trial: Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=284, Recruiting, Sponsor: Ibn Sina Hospital
- ||| Enrollment closed, Trial primary completion date: LatinoSTYLE: Randomized Control Trial of Family-Based HIV Prevention for Latinos (clinicaltrials.gov) - Apr 16, 2015
P2, N=640, Active, not recruiting, Sponsor: University of South Florida
Trial primary completion date: Oct 2014 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2016
- | Trial completion, Trial primary completion date: LESS-TLH Versus LESS-LAVH (clinicaltrials.gov) - Apr 16, 2015
P3, N=76, Completed, Sponsor: CHA University
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jan 2014
- ||| New trial, HEOR: Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=80, Recruiting, Sponsor: AIDS Malignancy Clinical Trials Consortium
- danvatirsen (AZD9150) / AstraZeneca, Flamingo Therapeutics
New P2 trial: AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites (clinicaltrials.gov) - Apr 16, 2015
P2, N=15, Recruiting, Sponsor: National Cancer Institute (NCI)
- Enrollment open, Enrollment change: Connecting Healthy Women: Examining the Effect of an Intervention From the Effect of Being Reachable (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=2100, Recruiting, Sponsor: University of Arizona
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jan 2014 Not yet recruiting --> Recruiting | N=1000 --> 2100
- | Avastin (bevacizumab) / Roche
Trial completion: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer (clinicaltrials.gov) - Apr 16, 2015
P2, N=50, Completed, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting | N=1000 --> 2100 Recruiting --> Completed
- New trial: Effect of the Glycemic Index of Diet on Metabolic and Reproductive Parameters in Overweight and Obese Infertile Women (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=45, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
- Norditropin (somatropin) / Novo Nordisk
Enrollment closed: Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=2000, Active, not recruiting, Sponsor: Novo Nordisk A/S
Recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- | Trial completion: Project Sexual Awareness for Everyone (SAFE) (clinicaltrials.gov) - Apr 15, 2015
P3, N=800, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion: Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=400, Completed, Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open, Surgery: Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=110, Recruiting, Sponsor: Case Comprehensive Cancer Center
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial primary completion date: Evaluation of the Effectiveness of the POWER Through Choices Program (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=1039, Active, not recruiting, Sponsor: Mathematica Policy Research, Inc.
Not yet recruiting --> Recruiting Trial primary completion date: Jul 2014 --> Jul 2015
- Trial termination: Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=150, Terminated, Sponsor: Mayo Clinic
Trial primary completion date: Jul 2014 --> Jul 2015 Suspended --> Terminated; Implantation rate significantly lower in treatment group than Controls.
- Trial initiation date: Utility of Fallopian Tube Cocultures in Assisted Reproductive Technology (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=15, Not yet recruiting, Sponsor: Weill Medical College of Cornell University
Suspended --> Terminated; Implantation rate significantly lower in treatment group than Controls. Initiation date: Dec 2014 --> Sep 2015